Sustained effects of interatrial shunt device on exercise hemodynamics in patients with heart failure with preserved and mid-range ejection fraction: 1-year efficacy data of the REDUCE LAP-HF trial
29 April 2017 (08:30 - 17:30)
Organised by:
Abstract
About the speaker
Cardiovascular Research Foundation, New York (United States of America)
34 More presentations in this session
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April 2017
08:30 CET
